These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8218262)

  • 1. Inhibition of protein kinase C by N-myristoylated peptide substrate analogs.
    Ward NE; O'Brian CA
    Biochemistry; 1993 Nov; 32(44):11903-9. PubMed ID: 8218262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; Earnest LE; van Boom JH; Fan D
    Invest New Drugs; 1991 May; 9(2):169-79. PubMed ID: 1874600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; van Boom JH
    Biochem Pharmacol; 1990 Jan; 39(1):49-57. PubMed ID: 2153382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible inactivation of protein kinase C by a peptide-substrate analog.
    Ward NE; Gravitt KR; O'Brian CA
    J Biol Chem; 1995 Apr; 270(14):8056-60. PubMed ID: 7713907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
    Ward NE; O'Brian CA
    Mol Pharmacol; 1992 Feb; 41(2):387-92. PubMed ID: 1538715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor.
    Eichholtz T; de Bont DB; de Widt J; Liskamp RM; Ploegh HL
    J Biol Chem; 1993 Jan; 268(3):1982-6. PubMed ID: 8420972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of myristoylated alanine-rich protein kinase C substrate to phosphoinositides attenuates the phosphorylation by protein kinase C.
    Seki K; Sheu FS; Huang KP
    Arch Biochem Biophys; 1996 Feb; 326(2):193-201. PubMed ID: 8611023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the ATPase activity of rat brain protein kinase C by phospho acceptor substrates of the enzyme.
    O'Brian CA; Ward NE
    Biochemistry; 1991 Mar; 30(9):2549-54. PubMed ID: 1848101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of protein kinase C isozymes by the inactivating peptide substrate analog N-biotinyl-Arg-Arg-Arg-Cys-Leu-Arg-Arg-Leu. Evidence that the biotinylated peptide is an active-site affinity label.
    Ward NE; Gravitt KR; O'Brian CA
    J Biol Chem; 1996 Sep; 271(39):24193-200. PubMed ID: 8798661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide substrate-based affinity label blocks protein kinase C-catalyzed ATP hydrolysis and peptide-substrate phosphorylation.
    Ward NE; Pierce DS; Stewart JR; O'brian CA
    Arch Biochem Biophys; 1999 May; 365(2):248-53. PubMed ID: 10328819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
    Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
    J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence.
    Kirwan AF; Bibby AC; Mvilongo T; Riedel H; Burke T; Millis SZ; Parissenti AM
    Biochem J; 2003 Jul; 373(Pt 2):571-81. PubMed ID: 12710889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein kinase C by retro-inverso pseudosubstrate analogues.
    Ricouart A; Tartar A; Sergheraert C
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1382-90. PubMed ID: 2514686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme.
    Ward NE; O'Brian CA
    Biochemistry; 1992 Jun; 31(25):5905-11. PubMed ID: 1535219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal processing of proteins by N-myristoylation. Substrate specificity of N-myristoyl transferase.
    Towler DA; Eubanks SR; Towery DS; Adams SP; Glaser L
    J Biol Chem; 1987 Jan; 262(3):1030-6. PubMed ID: 3100524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a myristoylated pseudosubstrate inhibitor of PKC in intact human platelets.
    Wheeler-Jones CP; Sayed S; Persaud SJ
    Biochem Soc Trans; 1995 May; 23(2):205S. PubMed ID: 7672225
    [No Abstract]   [Full Text] [Related]  

  • 17. ATP-sensitive binding of melittin to the catalytic domain of protein kinase C.
    O'Brian CA; Ward NE
    Mol Pharmacol; 1989 Sep; 36(3):355-9. PubMed ID: 2779522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
    Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.
    Stewart JR; Ward NE; Ioannides CG; O'Brian CA
    Biochemistry; 1999 Oct; 38(40):13244-51. PubMed ID: 10529197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of protein kinase C to N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide through its ATP binding site.
    O'Brian CA; Ward NE
    Biochem Pharmacol; 1989 Jun; 38(11):1737-42. PubMed ID: 2735931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.